Latest Mood stabilizers Stories
WOODCLIFF LAKE, N.J., April 25, 2014 /PRNewswire/ -- Eisai Inc.
Flood Law Group announced today that they are available to investigate the claims of parents of children who suffer from birth defects that are possibly linked to the prescription drug Depakote.
Upsher-Smith-sponsored data to include the first presentation of pooled Phase 1 data on the adverse event profile of USL255 (Qudexy(TM) XR (topiramate) extended-release capsules) MAPLE GROVE,
LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wb54w5/lithium_sulfate) has announced the addition of the "Lithium
Qudexy(TM) XR Offers Newest Option for Managing Certain Seizure Disorders and Marks the Company's Entrance into the Epilepsy Therapeutic Area MAPLE GROVE, Minn., March 12, 2014 /PRNewswire/
Researchers from the University of South Florida (USF) have reportedly discovered that an alternative salt form of lithium might be a safer, less toxic way to treat bipolar disorder...
The global market for histone deacetylase inhibitors (HDIs) was valued at $223.2 million in 2012 and was estimated at $361.8 million for 2013.
VANCOUVER, Jan. 28, 2014 /CNW Telbec/ - Sirocco Mining Inc. ("Sirocco") (TSX: SIM) and Canada Lithium Corp. ("Canada Lithium") (TSX: CLQ) (U.S.
- Growing in low tufty patches.